Study Finds High Prevalence of Medication-Induced Movement Disorders in Psychiatric Patients
A new study reveals that nearly 39% of psychiatric patients receiving regular follow-up care at an Ethiopian hospital experienced psychotropic medication-induced movement disorders.
Key points
- Prevalence of movement disorders reached 38.6% among psychiatric outpatients.
- First- and second-generation antipsychotics were linked to higher odds of symptoms.
- Longer illness duration and schizophrenia diagnosis increased risk.
Researchers investigating adverse effects in psychiatric care found that psychotropic medication-induced movement disorders affect more than one-third of patients undergoing regular follow-up. Conducted at the University of Gondar Hospital between October 1 and November 30, 2025, the institution-based cross-sectional study utilized the Extrapyramidal Symptom Rating Scale to assess participants selected through systematic random sampling. The overall prevalence of these movement disorders was identified at 38.6%.
The observational investigation highlights several factors linked to higher odds of developing these involuntary movements. Researchers noted that patients taking first-generation antipsychotics or second-generation antipsychotics faced significantly greater odds of movement disorders compared to those using antidepressants. Additionally, longer illness durations exceeding 10 years, a formal diagnosis of schizophrenia, and being single were associated with increased risk.
Because this was an observational cross-sectional study, it points to correlations rather than direct causation, and findings may reflect specific regional clinical populations. Authors emphasize that these adverse effects can cause substantial patient distress, stigma, and reduced medication adherence, meaning they require careful, routine clinical monitoring.
What to know: Over 38% of patients in the study experienced movement side effects linked to psychiatric medications, particularly antipsychotics and long-standing schizophrenia diagnoses. Always consult a qualified healthcare provider regarding personal treatment decisions and medication management.
Source Nature Health Sciences — nature.com/articles/s41598-026-78102-3 ↗
Read next
🏥Public HealthPreventive Services Task Force Resumes Meetings Under New Leadership
The U.S. Preventive Services Task Force is set to reconvene this week for the first time in over a year following a significant membership overhaul by Health Secretary Ro…
❤️Conditions & CareBlood-Based Genetic Signature May Predict CAR T-Cell Therapy Success in Lymphoma
Researchers have identified a specific RNA signature in blood plasma that may help predict how well lymphoma patients respond to CAR T-cell therapy.
🧠AI AnalysisUltraprocessed Diets May Impact Brain Reward Systems in Younger Adults
A Virginia Tech study suggests that individuals aged 18 to 21 may experience changes in brain reward processing after consuming ultraprocessed foods, a response not obser…
❤️Conditions & CareMigraine and Smoking Linked to Increased Early Stroke Risk in Women
A large-scale study suggests that people who have given birth and experience migraines while also smoking face a significantly higher risk of stroke before age 60.
🔬ResearchCBD Oil Found Ineffective for Managing Behavioral Issues in Youths with Intellectual Disabilities
A double-blind clinical trial published in JAMA Pediatrics indicates that CBD oil provides no significant behavioral improvement for children and teenagers with intellect…
🏃FitnessExpert Advice on Hydration Gear Sparks Debate Among Recreational Runners
Olympic medalist Josh Kerr recently suggested that runners may not require hydration packs for distances under 12 miles, igniting a broader conversation about gear necess…